Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
Regeneron
(https://regeneron.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Regeneron | Pushing the Bounds of Science (https://regeneron.com)
Title
Regeneron | Pushing the Bounds of Science
Meta
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
H2 Press releases for investors and media
H2 Our stories
H2 Creating a Healthier World
H2 Fueling the Future of Science
H2 The Regeneron Scientific Journey
H2 Voices of Generalized Myasthenia Gravis
H2 Rethinking Itch: A Window into Immunology
H2 doing well by doing good
H2 Careers at Regeneron
H2 Our clinical trials
H3 Press releases
H4 Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
H4 Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
H4 Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
NAV_HEADER_REPEATED_FOOTER Regeneron | Pushing the Bounds of Science (https://regeneron.com/contact/)
Title
Regeneron | Pushing the Bounds of Science
Meta
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
H2 Press releases for investors and media
H2 Our stories
H2 Creating a Healthier World
H2 Fueling the Future of Science
H2 The Regeneron Scientific Journey
H2 Voices of Generalized Myasthenia Gravis
H2 Rethinking Itch: A Window into Immunology
H2 doing well by doing good
H2 Careers at Regeneron
H2 Our clinical trials
H3 Press releases
H4 Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
H4 Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
H4 Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
NAV_HEADER_HEADING_REPEATED_BODY Regeneron | Pushing the Bounds of Science (https://regeneron.com/responsibility/our-approach/)
Title
Regeneron | Pushing the Bounds of Science
Meta
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
H2 Press releases for investors and media
H2 Our stories
H2 Creating a Healthier World
H2 Fueling the Future of Science
H2 The Regeneron Scientific Journey
H2 Voices of Generalized Myasthenia Gravis
H2 Rethinking Itch: A Window into Immunology
H2 doing well by doing good
H2 Careers at Regeneron
H2 Our clinical trials
H3 Press releases
H4 Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
H4 Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
H4 Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
NAV_HEADER_HEADING_REPEATED_BODY Regeneron | Pushing the Bounds of Science (https://regeneron.com/stories/featured/)
Title
Regeneron | Pushing the Bounds of Science
Meta
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
H2 Press releases for investors and media
H2 Our stories
H2 Creating a Healthier World
H2 Fueling the Future of Science
H2 The Regeneron Scientific Journey
H2 Voices of Generalized Myasthenia Gravis
H2 Rethinking Itch: A Window into Immunology
H2 doing well by doing good
H2 Careers at Regeneron
H2 Our clinical trials
H3 Press releases
H4 Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO
H4 Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
H4 Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://regeneron.com) Regeneron | Pushing the Bounds of Science
[IMG: In It For Good] [IMG: In It For Good] Nearly 50 candidates in development. 15 approved medicines developed in-house. One relentless scientific mission. Watch the video [H2] Press releases for investors and media Visit our newsroom Stay current on Regeneron news and company updates Follow us [IMG: LinkedIn logo] [IMG: Instagram logo] [IMG: Facebook logo] [IMG: YouTube logo] [IMG: X logo] Jun 04 [H4] Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO Read more May 28 [H4] Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak Read more May 22 [H4] Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss Read more Visit our newsroom [H2] Our stories See all stories [H2] Creating a Healthier World Learn about what’s next for responsibility at Regeneron Learn more [H2] Fueling the Future of Science A second decade of the Regeneron Science Talent Search Learn more [H2] The Regeneron Scientific Journey A deep understanding of human biology guides our path to potential medicines Learn more [H2] Voices of Generalized Myasthenia Gravis Learn what life is like with generalized myasthenia gravis (gMG) Learn more [H2] Rethinking Itch: A Window into Immunology Join us for the latest episode of The Nucleus Learn more See all stories From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development. OUR MEDICINES OUR COMPANY OUR PIPELINE We're guided by our philosophy of [H2] doing well by doing good We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us. Learn about our approach to corporate responsibility [H2] Careers at Regeneron Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today. Join our team [H2] Our clinical trials Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you. Explore our clinical trials
4126 chars
SUB-PAGE (https://regeneron.com/contact/) Regeneron | Pushing the Bounds of Science
[IMG: In It For Good] [IMG: In It For Good] Nearly 50 candidates in development. 15 approved medicines developed in-house. One relentless scientific mission. Watch the video [H2] Press releases for investors and media Visit our newsroom Stay current on Regeneron news and company updates Follow us [IMG: LinkedIn logo] [IMG: Instagram logo] [IMG: Facebook logo] [IMG: YouTube logo] [IMG: X logo] Jun 04 [H4] Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO Read more May 28 [H4] Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak Read more May 22 [H4] Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss Read more Visit our newsroom [H2] Our stories See all stories [H2] Creating a Healthier World Learn about what’s next for responsibility at Regeneron Learn more [H2] Fueling the Future of Science A second decade of the Regeneron Science Talent Search Learn more [H2] The Regeneron Scientific Journey A deep understanding of human biology guides our path to potential medicines Learn more [H2] Voices of Generalized Myasthenia Gravis Learn what life is like with generalized myasthenia gravis (gMG) Learn more [H2] Rethinking Itch: A Window into Immunology Join us for the latest episode of The Nucleus Learn more See all stories From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development. OUR MEDICINES OUR COMPANY OUR PIPELINE We're guided by our philosophy of [H2] doing well by doing good We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us. Learn about our approach to corporate responsibility [H2] Careers at Regeneron Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today. Join our team [H2] Our clinical trials Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you. Explore our clinical trials
4126 chars
SUB-PAGE (https://regeneron.com/responsibility/our-approach/) Regeneron | Pushing the Bounds of Science
[IMG: In It For Good] [IMG: In It For Good] Nearly 50 candidates in development. 15 approved medicines developed in-house. One relentless scientific mission. Watch the video [H2] Press releases for investors and media Visit our newsroom Stay current on Regeneron news and company updates Follow us [IMG: LinkedIn logo] [IMG: Instagram logo] [IMG: Facebook logo] [IMG: YouTube logo] [IMG: X logo] Jun 04 [H4] Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO Read more May 28 [H4] Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak Read more May 22 [H4] Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss Read more Visit our newsroom [H2] Our stories See all stories [H2] Creating a Healthier World Learn about what’s next for responsibility at Regeneron Learn more [H2] Fueling the Future of Science A second decade of the Regeneron Science Talent Search Learn more [H2] The Regeneron Scientific Journey A deep understanding of human biology guides our path to potential medicines Learn more [H2] Voices of Generalized Myasthenia Gravis Learn what life is like with generalized myasthenia gravis (gMG) Learn more [H2] Rethinking Itch: A Window into Immunology Join us for the latest episode of The Nucleus Learn more See all stories From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development. OUR MEDICINES OUR COMPANY OUR PIPELINE We're guided by our philosophy of [H2] doing well by doing good We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us. Learn about our approach to corporate responsibility [H2] Careers at Regeneron Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today. Join our team [H2] Our clinical trials Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you. Explore our clinical trials
4126 chars
SUB-PAGE (https://regeneron.com/stories/featured/) Regeneron | Pushing the Bounds of Science
[IMG: In It For Good] [IMG: In It For Good] Nearly 50 candidates in development. 15 approved medicines developed in-house. One relentless scientific mission. Watch the video [H2] Press releases for investors and media Visit our newsroom Stay current on Regeneron news and company updates Follow us [IMG: LinkedIn logo] [IMG: Instagram logo] [IMG: Facebook logo] [IMG: YouTube logo] [IMG: X logo] Jun 04 [H4] Regeneron to Highlight Progress Across Its Metabolic Disease, Ophthalmology and Rare Disease Pipelines at ADA and ENDO Read more May 28 [H4] Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak Read more May 22 [H4] Otarmeni™ (lunsotogene parvec) Receives EMA Filing Acceptance for Genetic Hearing Loss Read more Visit our newsroom [H2] Our stories See all stories [H2] Creating a Healthier World Learn about what’s next for responsibility at Regeneron Learn more [H2] Fueling the Future of Science A second decade of the Regeneron Science Talent Search Learn more [H2] The Regeneron Scientific Journey A deep understanding of human biology guides our path to potential medicines Learn more [H2] Voices of Generalized Myasthenia Gravis Learn what life is like with generalized myasthenia gravis (gMG) Learn more [H2] Rethinking Itch: A Window into Immunology Join us for the latest episode of The Nucleus Learn more See all stories From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development. OUR MEDICINES OUR COMPANY OUR PIPELINE We're guided by our philosophy of [H2] doing well by doing good We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us. Learn about our approach to corporate responsibility [H2] Careers at Regeneron Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today. Join our team [H2] Our clinical trials Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you. Explore our clinical trials
4126 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
12Review mentions (all pages)
8External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 3 | 2 |
| /contact/ | 3 | 2 |
| /responsibility/our-approach/ | 3 | 2 |
| /stories/featured/ | 3 | 2 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.regeneron.com",
"name": "Home",
"headline": "Regeneron | Pushing the Bounds of Science",
"description": "Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create lifechanging medicines. Join our team and explore clinical trials.",
"mainContentOfPage": [
{
"@type": "SiteNavigationElement",
"name": "About",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "SiteNavigationElement",
"name": "Science",
"url": "https://www.regeneron.com/science/investigational-pipeline"
},
{
"@type": "SiteNavigationElement",
"name": "Medicines",
"url": "https://www.regeneron.com/medicines/our-medicines"
},
{
"@type": "SiteNavigationElement",
"name": "Responsibility",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "SiteNavigationElement",
"name": "Stories",
"url": "https://www.regeneron.com/stories/featured"
}
],
"breadcrumb": [
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": "1",
"name": "Home",
"item": "https://www.regeneron.com"
}
]
}
],
"potentialAction": [
{
"@type": "ViewAction",
"name": "See what drives us",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "ViewAction",
"name": "Learn more about Radical Innovation for Humanity",
"url": "https://www.regeneron.comstories/radical-innovation-george-yancopoulos"
},
{
"@type": "ViewAction",
"name": "Learn how we support future STEM talent",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"url": "https://www.regeneron.com/responsibility/stem-ecosystem-support/sts"
},
{
"@type": "ViewAction",
"name": "Find out how we're building the medicines of tomorrow",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Visit our newsroom",
"description": "Stay current on Regeneron news and company updates",
"url": "https://investor.regeneron.com"
},
{
"@type": "ViewAction",
"name": "Learn about our Research and Development efforts",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Learn about our approach to corporate responsibility",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "ViewAction",
"name": "Join our team",
"description": "Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.",
"url": "https://careers.regeneron.com/"
},
{
"@type": "ViewAction",
"name": "Explore our clinical trials",
"description": "Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.",
"url": "https://clinicaltrials.regeneron.com/"
}
],
"video": [
{
"@type": "VideoObject",
"name": "Regeneron: Meant for More",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT01M39S",
"embedUrl": "https://player.vimeo.com/video/945873223"
},
{
"@type": "VideoObject",
"name": "Regeneron ISEF: A Program of Society for Science",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/6af089e3-e96e-4ce6-b108-e3ddefa13cac/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M59S",
"embedUrl": "https://player.vimeo.com/video/882648601"
},
{
"@type": "VideoObject",
"name": "Regeneron: Spectacular Science",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/64efb71c-1400-4642-853f-be365fb4c96b/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M25S",
"embedUrl": "https://player.vimeo.com/video/735435161"
},
{
"@type": "VideoObject",
"name": "Regeneron: Life-Changing Medicines",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/44587c69-80e7-4629-ac21-de8c2f2bc697/video-thumb-home-life-changing-medicines.jpg",
"uploadDate": "2024-12-03",
"duration": "PT03M50S",
"embedUrl": "https://player.vimeo.com/video/930750815"
},
{
"@type": "VideoObject",
"name": "Regeneron: Doing Well by Doing Good",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/1cc580f9-9ff0-4695-aeab-2a1affaafc33/vidThumb-responsibility-approach-hero.png",
"uploadDate": "2024-12-03",
"duration": "PT02M34S",
"embedUrl": "https://player.vimeo.com/video/930751500"
}
],
"provider": {
"@type": "Organization",
"@id": "https://www.regeneron.com/#organization",
"name": "Regeneron",
"url": "https://www.regeneron.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.regeneron.com/images/logo/logo.svg"
},
"description": "Regeneron is a biotechnology company focused on inventing, developing, and commercializing medicines for serious diseases.",
"tickerSymbol": "NASDAQ:REGN",
"address": {
"@type": "PostalAddress",
"streetAddress": "777 Old Saw Mill River Road",
"addressLocality": "Tarrytown",
"addressRegion": "NY",
"postalCode": "10591",
"addressCountry": "US"
},
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-914-847-7000",
"contactType": "headquarters",
"areaServed": "US",
"availableLanguage": "English"
},
"sameAs": [
"https://www.linkedin.com/company/regeneron-pharmaceuticals",
"https://www.instagram.com/regeneron/",
"https://www.facebook.com/Regeneron/",
"https://www.youtube.com/c/Regeneron",
"https://x.com/regeneron",
"https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
"https://www.wikidata.org/wiki/Q7308054",
"https://www.crunchbase.com/organization/regeneron-pharmaceuticals",
"https://www.nasdaq.com/market-activity/stocks/regn",
"https://www.reuters.com/companies/REGN.O"
]
}
}
/contact/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.regeneron.com",
"name": "Home",
"headline": "Regeneron | Pushing the Bounds of Science",
"description": "Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create lifechanging medicines. Join our team and explore clinical trials.",
"mainContentOfPage": [
{
"@type": "SiteNavigationElement",
"name": "About",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "SiteNavigationElement",
"name": "Science",
"url": "https://www.regeneron.com/science/investigational-pipeline"
},
{
"@type": "SiteNavigationElement",
"name": "Medicines",
"url": "https://www.regeneron.com/medicines/our-medicines"
},
{
"@type": "SiteNavigationElement",
"name": "Responsibility",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "SiteNavigationElement",
"name": "Stories",
"url": "https://www.regeneron.com/stories/featured"
}
],
"breadcrumb": [
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": "1",
"name": "Home",
"item": "https://www.regeneron.com"
}
]
}
],
"potentialAction": [
{
"@type": "ViewAction",
"name": "See what drives us",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "ViewAction",
"name": "Learn more about Radical Innovation for Humanity",
"url": "https://www.regeneron.comstories/radical-innovation-george-yancopoulos"
},
{
"@type": "ViewAction",
"name": "Learn how we support future STEM talent",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"url": "https://www.regeneron.com/responsibility/stem-ecosystem-support/sts"
},
{
"@type": "ViewAction",
"name": "Find out how we're building the medicines of tomorrow",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Visit our newsroom",
"description": "Stay current on Regeneron news and company updates",
"url": "https://investor.regeneron.com"
},
{
"@type": "ViewAction",
"name": "Learn about our Research and Development efforts",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Learn about our approach to corporate responsibility",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "ViewAction",
"name": "Join our team",
"description": "Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.",
"url": "https://careers.regeneron.com/"
},
{
"@type": "ViewAction",
"name": "Explore our clinical trials",
"description": "Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.",
"url": "https://clinicaltrials.regeneron.com/"
}
],
"video": [
{
"@type": "VideoObject",
"name": "Regeneron: Meant for More",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT01M39S",
"embedUrl": "https://player.vimeo.com/video/945873223"
},
{
"@type": "VideoObject",
"name": "Regeneron ISEF: A Program of Society for Science",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/6af089e3-e96e-4ce6-b108-e3ddefa13cac/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M59S",
"embedUrl": "https://player.vimeo.com/video/882648601"
},
{
"@type": "VideoObject",
"name": "Regeneron: Spectacular Science",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/64efb71c-1400-4642-853f-be365fb4c96b/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M25S",
"embedUrl": "https://player.vimeo.com/video/735435161"
},
{
"@type": "VideoObject",
"name": "Regeneron: Life-Changing Medicines",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/44587c69-80e7-4629-ac21-de8c2f2bc697/video-thumb-home-life-changing-medicines.jpg",
"uploadDate": "2024-12-03",
"duration": "PT03M50S",
"embedUrl": "https://player.vimeo.com/video/930750815"
},
{
"@type": "VideoObject",
"name": "Regeneron: Doing Well by Doing Good",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/1cc580f9-9ff0-4695-aeab-2a1affaafc33/vidThumb-responsibility-approach-hero.png",
"uploadDate": "2024-12-03",
"duration": "PT02M34S",
"embedUrl": "https://player.vimeo.com/video/930751500"
}
],
"provider": {
"@type": "Organization",
"@id": "https://www.regeneron.com/#organization",
"name": "Regeneron",
"url": "https://www.regeneron.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.regeneron.com/images/logo/logo.svg"
},
"description": "Regeneron is a biotechnology company focused on inventing, developing, and commercializing medicines for serious diseases.",
"tickerSymbol": "NASDAQ:REGN",
"address": {
"@type": "PostalAddress",
"streetAddress": "777 Old Saw Mill River Road",
"addressLocality": "Tarrytown",
"addressRegion": "NY",
"postalCode": "10591",
"addressCountry": "US"
},
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-914-847-7000",
"contactType": "headquarters",
"areaServed": "US",
"availableLanguage": "English"
},
"sameAs": [
"https://www.linkedin.com/company/regeneron-pharmaceuticals",
"https://www.instagram.com/regeneron/",
"https://www.facebook.com/Regeneron/",
"https://www.youtube.com/c/Regeneron",
"https://x.com/regeneron",
"https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
"https://www.wikidata.org/wiki/Q7308054",
"https://www.crunchbase.com/organization/regeneron-pharmaceuticals",
"https://www.nasdaq.com/market-activity/stocks/regn",
"https://www.reuters.com/companies/REGN.O"
]
}
}
/responsibility/our-approach/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.regeneron.com",
"name": "Home",
"headline": "Regeneron | Pushing the Bounds of Science",
"description": "Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create lifechanging medicines. Join our team and explore clinical trials.",
"mainContentOfPage": [
{
"@type": "SiteNavigationElement",
"name": "About",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "SiteNavigationElement",
"name": "Science",
"url": "https://www.regeneron.com/science/investigational-pipeline"
},
{
"@type": "SiteNavigationElement",
"name": "Medicines",
"url": "https://www.regeneron.com/medicines/our-medicines"
},
{
"@type": "SiteNavigationElement",
"name": "Responsibility",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "SiteNavigationElement",
"name": "Stories",
"url": "https://www.regeneron.com/stories/featured"
}
],
"breadcrumb": [
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": "1",
"name": "Home",
"item": "https://www.regeneron.com"
}
]
}
],
"potentialAction": [
{
"@type": "ViewAction",
"name": "See what drives us",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "ViewAction",
"name": "Learn more about Radical Innovation for Humanity",
"url": "https://www.regeneron.comstories/radical-innovation-george-yancopoulos"
},
{
"@type": "ViewAction",
"name": "Learn how we support future STEM talent",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"url": "https://www.regeneron.com/responsibility/stem-ecosystem-support/sts"
},
{
"@type": "ViewAction",
"name": "Find out how we're building the medicines of tomorrow",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Visit our newsroom",
"description": "Stay current on Regeneron news and company updates",
"url": "https://investor.regeneron.com"
},
{
"@type": "ViewAction",
"name": "Learn about our Research and Development efforts",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Learn about our approach to corporate responsibility",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "ViewAction",
"name": "Join our team",
"description": "Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.",
"url": "https://careers.regeneron.com/"
},
{
"@type": "ViewAction",
"name": "Explore our clinical trials",
"description": "Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.",
"url": "https://clinicaltrials.regeneron.com/"
}
],
"video": [
{
"@type": "VideoObject",
"name": "Regeneron: Meant for More",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT01M39S",
"embedUrl": "https://player.vimeo.com/video/945873223"
},
{
"@type": "VideoObject",
"name": "Regeneron ISEF: A Program of Society for Science",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/6af089e3-e96e-4ce6-b108-e3ddefa13cac/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M59S",
"embedUrl": "https://player.vimeo.com/video/882648601"
},
{
"@type": "VideoObject",
"name": "Regeneron: Spectacular Science",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/64efb71c-1400-4642-853f-be365fb4c96b/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M25S",
"embedUrl": "https://player.vimeo.com/video/735435161"
},
{
"@type": "VideoObject",
"name": "Regeneron: Life-Changing Medicines",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/44587c69-80e7-4629-ac21-de8c2f2bc697/video-thumb-home-life-changing-medicines.jpg",
"uploadDate": "2024-12-03",
"duration": "PT03M50S",
"embedUrl": "https://player.vimeo.com/video/930750815"
},
{
"@type": "VideoObject",
"name": "Regeneron: Doing Well by Doing Good",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/1cc580f9-9ff0-4695-aeab-2a1affaafc33/vidThumb-responsibility-approach-hero.png",
"uploadDate": "2024-12-03",
"duration": "PT02M34S",
"embedUrl": "https://player.vimeo.com/video/930751500"
}
],
"provider": {
"@type": "Organization",
"@id": "https://www.regeneron.com/#organization",
"name": "Regeneron",
"url": "https://www.regeneron.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.regeneron.com/images/logo/logo.svg"
},
"description": "Regeneron is a biotechnology company focused on inventing, developing, and commercializing medicines for serious diseases.",
"tickerSymbol": "NASDAQ:REGN",
"address": {
"@type": "PostalAddress",
"streetAddress": "777 Old Saw Mill River Road",
"addressLocality": "Tarrytown",
"addressRegion": "NY",
"postalCode": "10591",
"addressCountry": "US"
},
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-914-847-7000",
"contactType": "headquarters",
"areaServed": "US",
"availableLanguage": "English"
},
"sameAs": [
"https://www.linkedin.com/company/regeneron-pharmaceuticals",
"https://www.instagram.com/regeneron/",
"https://www.facebook.com/Regeneron/",
"https://www.youtube.com/c/Regeneron",
"https://x.com/regeneron",
"https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
"https://www.wikidata.org/wiki/Q7308054",
"https://www.crunchbase.com/organization/regeneron-pharmaceuticals",
"https://www.nasdaq.com/market-activity/stocks/regn",
"https://www.reuters.com/companies/REGN.O"
]
}
}
/stories/featured/
{
"@context": "http://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.regeneron.com",
"name": "Home",
"headline": "Regeneron | Pushing the Bounds of Science",
"description": "Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create lifechanging medicines. Join our team and explore clinical trials.",
"mainContentOfPage": [
{
"@type": "SiteNavigationElement",
"name": "About",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "SiteNavigationElement",
"name": "Science",
"url": "https://www.regeneron.com/science/investigational-pipeline"
},
{
"@type": "SiteNavigationElement",
"name": "Medicines",
"url": "https://www.regeneron.com/medicines/our-medicines"
},
{
"@type": "SiteNavigationElement",
"name": "Responsibility",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "SiteNavigationElement",
"name": "Stories",
"url": "https://www.regeneron.com/stories/featured"
}
],
"breadcrumb": [
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": "1",
"name": "Home",
"item": "https://www.regeneron.com"
}
]
}
],
"potentialAction": [
{
"@type": "ViewAction",
"name": "See what drives us",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"url": "https://www.regeneron.com/about/our-company"
},
{
"@type": "ViewAction",
"name": "Learn more about Radical Innovation for Humanity",
"url": "https://www.regeneron.comstories/radical-innovation-george-yancopoulos"
},
{
"@type": "ViewAction",
"name": "Learn how we support future STEM talent",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"url": "https://www.regeneron.com/responsibility/stem-ecosystem-support/sts"
},
{
"@type": "ViewAction",
"name": "Find out how we're building the medicines of tomorrow",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Visit our newsroom",
"description": "Stay current on Regeneron news and company updates",
"url": "https://investor.regeneron.com"
},
{
"@type": "ViewAction",
"name": "Learn about our Research and Development efforts",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"url": "https://www.regeneron.com/science/research-development"
},
{
"@type": "ViewAction",
"name": "Learn about our approach to corporate responsibility",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"url": "https://www.regeneron.com/responsibility/our-approach"
},
{
"@type": "ViewAction",
"name": "Join our team",
"description": "Join the brightest, most passionate innovators in science. Find your next opportunity by applying for jobs and internships at Regeneron today.",
"url": "https://careers.regeneron.com/"
},
{
"@type": "ViewAction",
"name": "Explore our clinical trials",
"description": "Our journey of discovery continues as we strive to transform the lives of people with serious diseases. Discover more about our clinical trials or locate a relevant trial near you.",
"url": "https://clinicaltrials.regeneron.com/"
}
],
"video": [
{
"@type": "VideoObject",
"name": "Regeneron: Meant for More",
"description": "At Regeneron, we move science to medicine because our world is meant for more.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/b0b99dd1-a93d-4857-8539-5b664c1440f5/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT01M39S",
"embedUrl": "https://player.vimeo.com/video/945873223"
},
{
"@type": "VideoObject",
"name": "Regeneron ISEF: A Program of Society for Science",
"description": "The Regeneron Science Talent Search and International Science and Engineering Fair have provided education and career pathways for ~2.4M STEM students since 2020.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/6af089e3-e96e-4ce6-b108-e3ddefa13cac/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M59S",
"embedUrl": "https://player.vimeo.com/video/882648601"
},
{
"@type": "VideoObject",
"name": "Regeneron: Spectacular Science",
"description": "We harmonize biology and technology, marrying the best of both to revolutionize research on how we target and aim to treat serious diseases.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/64efb71c-1400-4642-853f-be365fb4c96b/attachment.aspx",
"uploadDate": "2024-12-03",
"duration": "PT00M25S",
"embedUrl": "https://player.vimeo.com/video/735435161"
},
{
"@type": "VideoObject",
"name": "Regeneron: Life-Changing Medicines",
"description": "We’re driven by the pursuit of scientific breakthroughs, seeking innovative solutions for people facing serious diseases. From biologics to genetic medicines, our journey turns cutting-edge science into transformative medicine, redefining excellence and efficiency in research and development.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/44587c69-80e7-4629-ac21-de8c2f2bc697/video-thumb-home-life-changing-medicines.jpg",
"uploadDate": "2024-12-03",
"duration": "PT03M50S",
"embedUrl": "https://player.vimeo.com/video/930750815"
},
{
"@type": "VideoObject",
"name": "Regeneron: Doing Well by Doing Good",
"description": "We’re dedicated to responsible business practices, integrating the highest standards of integrity into every facet of our operations. Our responsibility strategy addresses the issues that matter most to our business and our stakeholders — because we understand that our actions have a profound impact on the world around us.",
"thumbnailUrl": "https://www.regeneron.com/getattachment/1cc580f9-9ff0-4695-aeab-2a1affaafc33/vidThumb-responsibility-approach-hero.png",
"uploadDate": "2024-12-03",
"duration": "PT02M34S",
"embedUrl": "https://player.vimeo.com/video/930751500"
}
],
"provider": {
"@type": "Organization",
"@id": "https://www.regeneron.com/#organization",
"name": "Regeneron",
"url": "https://www.regeneron.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.regeneron.com/images/logo/logo.svg"
},
"description": "Regeneron is a biotechnology company focused on inventing, developing, and commercializing medicines for serious diseases.",
"tickerSymbol": "NASDAQ:REGN",
"address": {
"@type": "PostalAddress",
"streetAddress": "777 Old Saw Mill River Road",
"addressLocality": "Tarrytown",
"addressRegion": "NY",
"postalCode": "10591",
"addressCountry": "US"
},
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-914-847-7000",
"contactType": "headquarters",
"areaServed": "US",
"availableLanguage": "English"
},
"sameAs": [
"https://www.linkedin.com/company/regeneron-pharmaceuticals",
"https://www.instagram.com/regeneron/",
"https://www.facebook.com/Regeneron/",
"https://www.youtube.com/c/Regeneron",
"https://x.com/regeneron",
"https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals",
"https://www.wikidata.org/wiki/Q7308054",
"https://www.crunchbase.com/organization/regeneron-pharmaceuticals",
"https://www.nasdaq.com/market-activity/stocks/regn",
"https://www.reuters.com/companies/REGN.O"
]
}
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 783 businesses audited.
⚠ More BS than average
Regeneron has 2.3 points more BS than the average for Medical Devices, Pharma & Biotech.
BS Detector
Medical Devices, Pharma & Biotech BS: Regeneron (regeneron.com)
https://regeneron.com
📍 Industry: Medical Devices, Pharma & Biotech
43
BS / 100
Regeneron provides high-substance evidence in its press releases but suffers from significant technical BS where sub-pages are merely mirrors of the homepage. The core scientific data is current and impressive, but the web architecture’s redundancy suggests a template-first marketing strategy that dilutes the brand’s authority. It is a legitimate scientific leader currently trapped in a low-effort content management implementation.
Info Density
Power-words vs. Substance ratio.
12
40% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
10
50% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
6
30% BS
Commodity Fingerprint
Detection of industry clichés/templates.
9
60% BS
Identity & Authority
Expert verifiability & Schema depth.
6
40% BS
Eliminate the technical redundancy by replacing the duplicate homepage content on the Contact and Stories pages with unique, specific data. Replace the aspirational H2 headings with descriptive, noun-heavy titles like Phase 3 Clinical Trial Milestones or 2026 Corporate Responsibility Metrics. Integrate Person schema for key scientific officers to verify the scientific journey claims with individual digital footprints. Link the 2.4M STEM student claim directly to a third-party impact study or specific program page.
The content perfectly aligns with the Pharma & Biotech industry, specifically highlighting pipeline development, clinical trials, and regulatory filings. References to EMA filing acceptance, WHO recommendations, and NASDAQ: REGN confirm the entity’s standing within the medical research sector.
“The score is driven primarily by Semantic Coherence and Information Density failures caused by the technical error of duplicating the homepage content across all sub-pages. While the company has high individual proof points, the technical execution on the web indicates high levels of template-driven fluff. The Trust and Proof pillar remains strong due to the freshness of the dated press releases and specific medicine counts.”
Verified Analysis Date: June 19, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from Regeneron, captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Regeneron: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://regeneron.com to view the most current version of its content and learn from the source what this company is about and what it offers.